Investigators are designing a clinical trial to evaluate the efficacy of a novel oral anticoagulant compared to standard therapy for preventing stroke in patients with atrial fibrillation. They utilize a randomized, double-blinded, parallel-group study design.
Which of the following statements correctly describe the methodological strengths and characteristics of this study design? (Select all that apply)
- The double-blinded methodology helps prevent ascertainment bias by keeping both the investigators and participants unaware of group assignment.Cevap
- The randomization process aims to equally distribute both known and unknown confounding variables across the treatment and control groups.Cevap
- CRandomization completely eliminates the possibility of effect modification within the patient population.
- DThe efficacy of the novel intervention is primarily evaluated by calculating positive and negative predictive values.
- EA paired t-test must be used to compare the incidence of stroke between the two independent treatment groups at the end of the study.
Cevap
The study design benefits from blinding to prevent ascertainment bias and randomization to evenly distribute known and unknown confounders.
The correct options accurately identify two fundamental strengths of randomized controlled trials (RCTs). Blinding prevents ascertainment bias by ensuring that subjective assessments are not influenced by treatment knowledge. Furthermore, randomization is unique among study designs in its ability to evenly distribute both known and unknown baseline confounding variables between intervention groups.
Adım Adım Çözüm
Anahtar Kavram
Methodological principles and strengths of randomized controlled trials (RCTs)
Tahmini Süre:1m 0s